
# references:
# 1. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing, Cell, 2017
# 2. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing, Nature Medicine, 2018
# 3. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer, Nature, 2018
# 4. https://en.wikipedia.org/wiki/Interleukin-7_receptor
# 5. CD8+ T cell states in human cancer: insights from single-cell analysis, Nature review cancer, 2020
# 6. Clonal replacement of tumor-specific T cells following PD-1 blockade, Nature medicine, 2019
# 7. https://www.wikigenes.org/e/gene/e/4118.html
# 8. https://en.wikipedia.org/wiki/CD44
# 9. Memory T Cell Subsets, Migration Patterns, and Tissue Residence, annual review immunology, 2013
# 10. https://en.wikipedia.org/wiki/CCR5
# 11. Three Memory Subsets of Human CD8 T Cells Differently Expressing Three Cytolytic Effector Molecules, 
# 12. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood
# 13. pan-T zhanglab
# 14. https://en.wikipedia.org/wiki/CXCR3
# 15. https://en.wikipedia.org/wiki/CXCR4
# 16. https://en.wikipedia.org/wiki/CCL4
# 17. https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR183
# 18. Memory T Cell Subsets, Migration Patterns, and Tissue Residence, Annual review
# 19. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZNF683
# 20. (2015). Functional classification of memory CD8(+) T cells by CX3CR1 expression. Nat. Commun.
# 21. https://en.wikipedia.org/wiki/KLRG1
# 22. Clonal replacement of tumor-specific T cells following PD-1 blockade, Nat Med 2019
# 23. Follicular Helper CD4 T Cells (TFH), Annual Reviews immunology, 2011
# 24. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade, Nature immunology 2019
# 25. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma, Cell, 2018
# 26. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy, Nature, 2016
# 27. Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy, Immunity, 2019
# 28. TOX is a critical regulator of tumour-specific T cell differentiation, Nature, 2019
# 29. https://www.cellsignal.com/products/primary-antibodies/nfat1-antibody/4389
# 30. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection, Nature, 2019
# 31. TOX transcript+ionally and epigenetically programs CD8 T cell exhaustion, Nature, 2019
# 32. https://en.wikipedia.org/wiki/SETBP1
# 33. https://en.wikipedia.org/wiki/IKZF2
# 34. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion, EMBO 2015
# 35. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells, Trends in immunology
# 36. NKG7 makes a better killer, Nature immunology, 2019
# 37. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation, Nature immunology, 2019
# 38. https://en.wikipedia.org/wiki/GNLY
# 39. Perforin and granzymes- function, dysfunction and human pathology, Nature review immunology, 2015
# 40. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51–59 (2009).
# 41. Mol. Cell. Biol. 7, 4472–4481 (1987). This paper identified CD28 as a co‐stimulator that could amplify TCR signalling to induce proliferation and IL‐2 production
# 42. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 229, 12–26 (2009).
# 43. T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, Science 2017
# 44. The storm has cleared- lessons from the CD28 superagonist TGN1412 trial, Nature reviews immunology, 2012
# 45. https://blog.crownbio.com/lag3-a-promising-new-cancer-immunotherapy-target
# 46. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF, Nature medicine 2010
# 47. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21, 401–413 (2004).
# 48. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201–1217 (2012).
# 49. T cell Ig and mucin domain- containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases. J. Immunol. 192, 782–791 (2014).
# 50. Molecular and cellular insights into T cell exhaustion, Nature reviews immunology 2015
# 51. Clinical blockade of PD1 and LAG3 — potential mechanisms of action, Nature reviews immunology, 2014
# 52. Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461–2472 (2006).
# 53. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma, Cell, 2019
# 54. Infected CD8α– dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection. Proc. Natl Acad. Sci. USA 109, 14116–14121 (2012).
# 55. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16, 452–459 (2010).
# 56. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection, PNAS, 2008
# 57. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 123, 2604–2615 (2013).
# 58. A Transcriptionally Distinct CXCL13þCD103þCD8þ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer, cancer immunology research 2019
# 59. https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCGR3A
# 60. https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFBP2
# 61. http://en.wikipedia.org/wiki/Common_gamma_chain
# 62. CYTOKINE CONTROL OF MEMORY T-CELL DEVELOPMENT AND SURVIVAL, Nature reviews immunology, 2003
# 63. The integration of T cell migration, differentiation and function, Nature reviews immunology, 2013
# 64. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANXA1
# 65. IL-17 and Th17 Cells, annual reviews immunology, 2009
# 66. Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling, cancer immunology research 2020
# 67. ST2 as checkpoint target for colorectal cancer immunotherapy, JCI insight, 2019
# 68. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, Science, 2016
# 69. Tumor-Derived IL33 Promotes Tissue-Resident CD8 + T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy,  cancer immunology research 2020
# 70. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma, NEJM, 2016
# 71. S-100 protein: is it useful as a tumour marker in diagnostic immunocytochemistry?, 1980
# 72. interferon-Gamma at the Crossroads of Tumor immune Surveillance or evasion, frontieres immunology, 2018
# 73. Resistance to checkpoint blockade therapy through inactivation of antigen presentation, Nature communication, 2017
# 74. https://www.genecards.org/cgi-bin/carddisp.pl?gene=HMGB2
# 75. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CKS1B
# 76. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis, Nature medicine, 2018
# 77. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL5
# 78. https://www.sciencedirect.com/topics/neuroscience/ccl5
# 79. https://www.genecards.org/cgi-bin/carddisp.pl?gene=INPP5F
# 80. https://www.genecards.org/cgi-bin/carddisp.pl?gene=MYO1E
# 81. https://www.genecards.org/cgi-bin/carddisp.pl?gene=MYO7A
# 82. Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade, Cell, 2017
# 83. https://genecards.weizmann.ac.il/v3/cgi-bin/carddisp.pl?gene=ITGA1
# 84. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates, Nature 2018
# 85. Targeting CD39 in cancer, Nature reviews immunology
# 86. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8 + T Cells, cancer research 2018
# 87. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors, Nature communication, 2018
# 88. https://www.cellsignal.com/contents/science-cst-pathways-immunology-inflammation/tumor-infiltrating-immune-cell-markers-(human)/pathways-ti-icm-human
# 89. https://en.wikipedia.org/wiki/Neural_cell_adhesion_molecule
# 90. https://en.wikipedia.org/wiki/NKG2D
# 91. https://en.wikipedia.org/wiki/NKG2
# 92. https://www.innate-pharma.com/en/pipeline/monalizumab-anti-nkg2a-mab-partnered-astrazeneca#:~:text=NKG2A%20is%20an%20inhibitory%20checkpoint%20receptor%20for%20HLA-E.,cells%20of%20many%20solid%20tumors%20and%20hematological%20malignancies.
# 93. https://www.genecards.org/cgi-bin/carddisp.pl?gene=KLRC1&keywords=KLRC1
# 94. The cancer–natural killer cell immunity cycle, Nature reviews cancer, 2020
# 95. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer, Nature 2020
# 96. The thioredoxin‐1 inhibitor Txnip restrains effector T‐cell and germinal center B‐cell expansion, european journal of immunology 2020
# 97. https://en.wikipedia.org/wiki/CD19
# 98. https://en.wikipedia.org/wiki/CD20
# 99. http://en.wikipedia.org/wiki/CD79A
# 100.  https://en.wikipedia.org/wiki/CXCR4
# 101. Tertiary lymphoid structures improve immunotherapy and survival in melanoma, Nature, 2020
# 102.  Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy, Nature cancer 2020
# 103. https://en.wikipedia.org/wiki/Interleukin_12
# 104. Interleukin 12: still a promising candidate for tumor immunotherapy? cancer immunology and immunotherapy , 2014
# 104. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours, Nature biomedical engineering 2020
# 105. The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function, Cell report 2018
# 106. Beigene 202007 investor conference R&D https://hkexir.beigene.com/media/1478/beigene_early_development_pipeline_and_research_deck-video-match20200709.pdf 
# 107. The Transcription Factor Foxp3 Shapes Regulatory T Cell Identity by Tuning the Activity of trans-Acting Intermediaries, Immunity, 2020
# 108. Production of the Cytokine VEGF-A by CD4+ T and Myeloid Cells Disrupts the Corneal Nerve Landscape and Promotes Herpes Stromal Keratitis , Immunity, 2020
# 109. Checkpoint inhibitor immunotherapy in kidney cancer, Nature reviews urology 2020
# 110. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation, immunity 2020
# 111. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCR2
# 112. https://en.wikipedia.org/wiki/Integrin_alpha_M
# 113. https://en.wikipedia.org/wiki/Integrin_alpha_X
# 114. Single-Cell Analyses Inform Mechanisms of MyeloidTargeted Therapies in Colon Cancer, Cell 2020
# 115. https://en.wikipedia.org/wiki/CD1
# 116. Batf3 deficiency reveals a critical role for CD8 + dendritic cells in cytotoxic T cell immunity, Science 2008
# 117. https://en.wikipedia.org/wiki/CXCL9
# 118. https://en.wikipedia.org/wiki/CXCL10
# 119. https://en.wikipedia.org/wiki/CXCL11
# 120. The Dendritic Cell Lineage- Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting, annual review immuno 2013
# 121. https://en.wikipedia.org/wiki/CD135
# 122. https://en.wikipedia.org/wiki/XCL1
# 123. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control, Cell 2018
# 124. Disruption of CCR5‐dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 2009
# 125. A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments, Nature medicine, 2018
# 126. https://en.wikipedia.org/wiki/Heat_shock_protein#Function_in_antigen_presentation
# 127. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas, Nature medicine, 2020
# 128. Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies, Cell, 2020
# 129. https://en.wikipedia.org/wiki/TAP1
# 130. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy, Cell, 2017
# 131. To TAP or not to TAP: alternative peptides for immunotherapy of cancer, current opinion, 2020
# 132. Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression, clinical cancer research 2014
# 133. Netrin G1 promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression, cancer discovery, 2020
# 134. IL-15 signaling in NK cell cancer immunotherapy, current opinion, 2017
# 135. http://en.wikipedia.org/wiki/PTPRC
# 136. https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPRC
# 137. https://www.genecards.org/cgi-bin/carddisp.pl?gene=PECAM1
# 138. https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDR
# 139. http://en.wikipedia.org/wiki/Epithelial_cell_adhesion_molecule
# 140. https://www.genecards.org/cgi-bin/carddisp.pl?gene=MS4A2
# 141. https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCER1A
# 142. Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection, cancer immunology research 2020
# 143. https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR1
# 144. http://en.wikipedia.org/wiki/CXCL16
# 145. An antibody targeting ICOS increases intratumoral cytotoxic to regulatory T cell ratio and induces tumor regression, Cancer immunology research, 2020
# 146. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy, Cell, 2020 
# 147. Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
# 148. http://en.wikipedia.org/wiki/LILRA4
# 149. Zhanglab pan myeloid
# 150. https://www.ncbi.nlm.nih.gov/gene/283420
# 151.  A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response, Nature comm
# 152. Dissecting_the_immunogenomic_biology_of_cancer_for_biomarker_development, Nr clinical oncology, 2020
# 153. http://en.wikipedia.org/wiki/CD135
# 154. Genomic Classification and Prognosis in Acute Myeloid Leukemia, NEJM, 2016
# 155. Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukemia: results from the phase III ADMIRAL trial [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2019.
# 156. https://www.onclive.com/view/gilteritinib-takes-step-toward-chinese-approval-for-emflt3em-aml
# 157. http://en.wikipedia.org/wiki/DNA_(cytosine-5)-methyltransferase_3A
# 158. Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia, cancer discovery 2019
# 159. https://www.sciencedirect.com/topics/medicine-and-dentistry/npm1
# 160. https://www.nature.com/articles/s43018-020-00155-8
# 161.  PD-1 Blockade in Mismatch-Repair Deficiency. NEJM
# 162.  https://www.biorxiv.org/content/10.1101/2020.12.15.422831v1, a crc omic analysis paper pauling suggested 2020
# 163. Melanoma-intrinsic b-catenin signalling prevents anti-tumour immunity, Nature 2015
# 164. Allele-Specific HLA Loss and Immune Escape in Lung, CELL
# 165.  EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer: a retrospective analysis. Clin. Cancer Res
# 166. Tumor-Antagonizing Fibroblasts Secrete Prolargin as Tumor Suppressor in Hepatocellular Carcinoma , bioarxiv 2021
# 167.  http://en.wikipedia.org/wiki/CCL22
# 168.  Antitumour immunity regulated by aberrant ERBB family signalling, Nat reviews, 2021






